Santen Pharmaceutical Co (SNPHF) Stock Forecast & Price Target
SNPHF Analyst Ratings
There are no analyst ratings in the last 3 months.
SNPHF Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
Best Analysts Covering Santen Pharmaceutical Co
Copying DeepSeek Drug Manufacturers - General's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +6.80% per trade.
Copying DeepSeek Drug Manufacturers - General's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +2.55% per trade.
Copying DeepSeek Drug Manufacturers - General's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +2.55% per trade.
SNPHF Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 1 | 1 | 1 | 0 |
In the current month, SNPHF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SNPHF average Analyst price target in the past 3 months is ―.
SNPHF Financial Forecast
SNPHF Earnings Forecast
Next quarter’s earnings estimate for SNPHF is $0.20 with a range of $0.15 to $0.25. The previous quarter’s EPS was $0.14. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
SNPHF Sales Forecast
Next quarter’s sales forecast for SNPHF is $461.14M with a range of $452.82M to $466.51M. The previous quarter’s sales results were $436.83M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
